4Dornhorst A, Laddeke HJ, Honka M, et al. PREDICTIVE Study Group. Safety and efficacy of insulin detemir basal-bolus therapy in type ] diabetes patients : 14-week data from the European cohorl of the PREDICTIVE study. Curt Med Res Opin ,2008,2A- :369-376.
5Yenigun M,Honka M.Switching patients from insulin glarine basedbasal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen:results from a subgroup of the PREDICTIVE study[].International Journal of Clinical Practice.2009
6Robertson RP,Harmon J,Tran PO,et al.Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection[].Diabetes.2003
7Del Prato S,Marchetti P,Bonadonna RC.Phasic insulin release and metabolic regulation in type 2 diabetes[].Diabetes.2002
8Riddle MC,Rosenstock J,Gerich J.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type2 diabetic patients[].Diabetes Care.2003
9Hirsch IB.Intensifying insulin therapy in patients with type 2diabetes mellitus[].The American Journal of Medicine.2005
10Halman RR,Paul SK,Bethel MA,et al. The New England Journal of Medicine . 2008
